Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
25 hedge funds and large institutions have $808K invested in Biocept, Inc. in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 5 closing their positions.
190% more call options, than puts
Call options by funds: $29K | Put options by funds: $10K
4% less funds holding
Funds holding: 26 → 25 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
49% less capital invested
Capital invested by funds: $1.57M → $808K (-$764K)
88% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$16.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$7.66K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$397 |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$265 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Globeflex Capital
San Diego,
California
|
-$215K |
| 2 |
Millennium Management
New York
|
-$34K |
| 3 |
Two Sigma Advisers
New York
|
-$13K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$12K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.56K |
BIOC Hedge Fund Activity: Q4 2022 in Review
25 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q4 2022, worth a combined $808K — down 49% from $1.57M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BIOC and 4 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 1 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $16.9K. The largest seller was Globeflex Capital, exiting entirely with an estimated $215K sold.
- 25 institutional investors held Biocept, Inc. (BIOC) as of Q4 2022, down from 26 in Q3 2022.
- Funds reported $808K of Biocept, Inc. stock for Q4 2022, down 49% quarter-over-quarter.
- 4 funds opened new Biocept, Inc. positions in Q4 2022 and 5 closed out, a net change of -1 holder.
- The largest Biocept, Inc. buyer in Q4 2022 was Virtu Financial, an estimated $16.9K added.
- The largest Biocept, Inc. seller in Q4 2022 was Globeflex Capital, an estimated $215K sold.
Based on aggregated 13F filings for Q4 2022.